b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Process" Owner="NLM">\n        <PMID Version="1">31216070</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>07</Month>\n            <Day>01</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1941-2444</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>44</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>01</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>JPEN. Journal of parenteral and enteral nutrition</Title>\n                <ISOAbbreviation>JPEN J Parenter Enteral Nutr</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>American Society for Parenteral and Enteral Nutrition Clinical Guidelines: The Validity of Body Composition Assessment in Clinical Populations.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>12-43</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1002/jpen.1669</ELocationID>\n            <Abstract>\n                <AbstractText>On behalf of the American Society for Parenteral and Enteral Nutrition (ASPEN), a systematic review was conducted to evaluate the best available evidence regarding the validity of relevant body composition methods (eg, dual energy X-ray absorptiometry [DXA], ultrasound [US], and bioelectrical impedance analysis [BIA]) in clinical populations. The guidelines targeted adults &gt;18\xc2\xa0years of age with a potentially inflammatory condition or pathological end point associated with a specific disease or clinical condition. In total, 7375 studies were retrieved, and 15 DXA, 7 US, and 23 BIA studies provided applicable data. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses was used to assess the diagnostic accuracy of the test method against a &quot;gold standard&quot; reference. The Grading of Recommendations, Assessment, Development and Evaluation criteria were used to separate the evaluation of the body of evidence from the recommendations. Based on a limited number of studies and expert opinion, DXA is recommended for the assessment of fat mass in patients with a variety of disease states; however, the validity of DXA for lean mass assessment in any clinical population remains unknown. No recommendations can be made at this time to support the use of US or BIA in the clinical setting, as data to support its validity in any specific patient population are limited in scope or by the proprietary nature of manufacture-specific BIA regression models to procure body composition data, respectively. Directions for future research are provided. These clinical guidelines were approved by the ASPEN Board of Directors.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2019 American Society for Parenteral and Enteral Nutrition.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Sheean</LastName>\n                    <ForeName>Patricia</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Marcella Niehoff School of Nursing, Department of Health Promotion, Loyola University Chicago, Maywood, Illinois, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gonzalez</LastName>\n                    <ForeName>M Cristina</ForeName>\n                    <Initials>MC</Initials>\n                    <Identifier Source="ORCID">0000-0002-3901-8182</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Postgraduate Program in Health and Behavior, Catholic University of Pelotas, Pelotas, Rio Grande do Sul, Brazil.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Prado</LastName>\n                    <ForeName>Carla M</ForeName>\n                    <Initials>CM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Human Nutrition Research Unit, Department of Agricultural, Food and Nutritional Science, Division of Human Nutrition, University of Alberta, Edmonton, Alberta, Canada.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>McKeever</LastName>\n                    <ForeName>Liam</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Kinesiology and Nutrition, University of Illinois, Chicago, Illinois, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hall</LastName>\n                    <ForeName>Amber M</ForeName>\n                    <Initials>AM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Braunschweig</LastName>\n                    <ForeName>Carol A</ForeName>\n                    <Initials>CA</Initials>\n                    <Identifier Source="ORCID">0000-0002-3914-0073</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Kinesiology and Nutrition and Division of Epidemiology and Biostatistics, University of Illinois at Chicago, Chicago, Illinois, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <Agency>CIHR</Agency>\n                    <Country>Canada</Country>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>06</Month>\n                <Day>19</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>JPEN J Parenter Enteral Nutr</MedlineTA>\n            <NlmUniqueID>7804134</NlmUniqueID>\n            <ISSNLinking>0148-6071</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">adult</Keyword>\n            <Keyword MajorTopicYN="Y">body composition</Keyword>\n            <Keyword MajorTopicYN="Y">nutrition assessment</Keyword>\n            <Keyword MajorTopicYN="Y">validity</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>07</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>09</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>20</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>20</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>20</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31216070</ArticleId>\n            <ArticleId IdType="doi">10.1002/jpen.1669</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Title>References</Title>\n            <Reference>\n                <Citation>Jensen GL, Cederholm T, Correia M, et\xc2\xa0al. GLIM criteria for the diagnosis of malnutrition: a consensus report from the global clinical nutrition community. JPEN J Parenter Enteral Nutr. 2018;38(1):1-9.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Heymsfield S. Human Body Composition. 2nd ed. Champaign, IL: Human Kinetics; 2005.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wang ZM, Pierson RN,Jr., Heymsfield SB. The five-level model: a new approach to organizing body-composition research. Am J Clin Nutr. 1992;56(1):19-28.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Druyan ME, Compher C, Boullata JI, et\xc2\xa0al. Clinical guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients: applying the GRADE system to development of A.S.P.E.N. clinical guidelines. JPEN J Parenter Enteral Nutr. 2012;36(1):77-80.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>McInnes MDF, Moher D, Thombs BD, et\xc2\xa0al. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. 2018;319(4):388-396.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>McKeever L, Nguyen V, Peterson SJ, Gomez-Perez S, Braunschweig C. Demystifying the search button: a comprehensive PubMed search strategy for performing an exhaustive literature review. JPEN J Parenter Enteral Nutr. 2015;39(6):622-635.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315(21):2284-2291.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Baracos VE, Reiman T, Mourtzakis M, Gioulbasanis I, Antoun S. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr. 2010;91(4):1133S-1137S.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107(6):931-936.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Martin L, Birdsell L, Macdonald N, et\xc2\xa0al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J. Clin. Oncol. 2013;31(12):1539-1547.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Prado CM, Lieffers JR, McCargar LJ, et\xc2\xa0al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629-635.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Cushen SJ, Power DG, Teo MY, et\xc2\xa0al. Body composition by computed tomography as a predictor of toxicity in patients with renal cell carcinoma treated with sunitinib. Am J Clin Oncol. 2014, 40(1):47-52.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Prado CM, Purcell SA, Alish C, et\xc2\xa0al. Implications of low muscle mass across the continuum of care: a narrative review. Ann Med. 2018;50(8):1-19.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Prado CM, Baracos VE, McCargar LJ, et\xc2\xa0al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009;15(8):2920-2926.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Caan BJ, Cespedes Feliciano EM, Prado CM, et\xc2\xa0al. Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer. JAMA Oncol. 2018;4(6):789-804.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Prado CM, Baracos VE, McCargar LJ, et\xc2\xa0al. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res. 2007;13(11):3264-3268.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Barret M, Antoun S, Dalban C, et\xc2\xa0al. Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer. Nutr Cancer. 2014;66(4):583-589.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Antoun S, Birdsell L, Sawyer MB, Venner P, Escudier B, Baracos VE. Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study. J Clin Oncol. 2010;28(6):1054-1060.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Huillard O, Mir O, Peyromaure M, et\xc2\xa0al. Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients. Br J Cancer. 2013;108(5):1034-1041.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Mir O, Coriat R, Blanchet B, et\xc2\xa0al. Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma. PLoS One. 2012;7(5):e37563.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Massicotte MH, Borget I, Broutin S, et\xc2\xa0al. Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study. J Clin Endocrinol Metab. 2013;98(6):2401-2408.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res. 2009;15(22):6973-6979.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, et\xc2\xa0al. Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol. 2015;6:e102.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Montano-Loza AJ, Meza-Junco J, Prado CM, et\xc2\xa0al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10(2):166-173, 173 e161.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Schols AM. Nutritional advances in patients with respiratory diseases. Eur Respir Rev. 2015;24(135):17-22.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Sheean PM, Peterson SJ, Gomez Perez S, et\xc2\xa0al. The prevalence of sarcopenia in patients with respiratory failure classified as normally nourished using computed tomography and subjective global assessment. JPEN J Parenter Enteral Nutr. 2014;38(7):873-879.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Josiak K, Jankowska EA, Piepoli MF, Banasiak W, Ponikowski P. Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones. J Cachexia Sarcopenia Muscle. 2014;5(4):287-296.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Dahya V, Xiao J, Prado CM, et\xc2\xa0al. Computed tomography-derived skeletal muscle index: a novel predictor of frailty and hospital length of stay after transcatheter aortic valve replacement. Am Heart J. 2016;182:21-27.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Roubenoff R. Sarcopenic obesity: does muscle loss cause fat gain? lessons from rheumatoid arthritis and osteoarthritis. Ann N Y Acad Sci. 2000;904:553-557.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lin TY, Peng CH, Hung SC, Tarng DC. Body composition is associated with clinical outcomes in patients with non-dialysis-dependent chronic kidney disease. Kidney Int. 2018;93(3):733-740.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ni Bhuachalla EB, Daly LE, Power DG, Cushen SJ, MacEneaney P, Ryan AM. Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition? J Cachexia Sarcopenia Muscle. 2018;9(2):295-305.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Tandon P, Ney M, Irwin I, et\xc2\xa0al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl. 2012;18(10):1209-1216.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Prado CM, Heymsfield SB. Lean tissue imaging: a new era for nutritional assessment and intervention. JPEN J Parenter Enteral Nutr. 2014;38(8):940-953.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Anjana M, Sandeep S, Deepa R, Vimaleswaran KS, Farooq S, Mohan V. Visceral and central abdominal fat and anthropometry in relation to diabetes in Asian Indians. Diabetes Care. 2004;27(12):2948-2953.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Baker ST, Strauss BJ, Prendergast LA, et\xc2\xa0al. Estimating dual-energy X-ray absorptiometry-derived total body skeletal muscle mass using single-slice abdominal magnetic resonance imaging in obese subjects with and without diabetes: a pilot study. Eur J Clin Nutr. 2012;66(5):628-632.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Greenfield JR, Samaras K, Chisholm DJ, Campbell LV. Regional intra-subject variability in abdominal adiposity limits usefulness of computed tomography. Obes Res. 2002;10(4):260-265.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Bredella MA, Ghomi RH, Thomas BJ, et\xc2\xa0al. Comparison of DXA and CT in the assessment of body composition in premenopausal women with obesity and anorexia nervosa. Obesity (Silver Spring). 2010;18(11):2227-2233.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Deschenes D, Couture P, Dupont P, Tchernof A. Subdivision of the subcutaneous adipose tissue compartment and lipid-lipoprotein levels in women. Obes Res. 2003;11(3):469-476.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Elisha B, Rabasa-Lhoret R, Messier V, Abdulnour J, Karelis AD. Relationship between the body adiposity index and cardiometabolic risk factors in obese postmenopausal women. Eur J Nutr. 2013;52(1):145-151.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Karelis AD, Rabasa-Lhoret R, Pompilus R, et\xc2\xa0al. Relationship between the Bertin index to estimate visceral adipose tissue from dual-energy X-ray absorptiometry and cardiometabolic risk factors before and after weight loss. Obesity (Silver Spring). 2012;20(4):886-890.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Miljkovic I, Cauley JA, Wang PY, et\xc2\xa0al. Abdominal myosteatosis is independently associated with hyperinsulinemia and insulin resistance among older men without diabetes. Obesity (Silver Spring). 2013;21(10):2118-2125.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Smith SR, Lovejoy JC, Greenway F, et\xc2\xa0al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism. 2001;50(4):425-435.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ganpule-Rao A, Joglekar C, Patkar D, et\xc2\xa0al. Associations of trunk fat depots with insulin resistance, beta cell function and glycaemia-a multiple technique study. PLoS One. 2013;8(10):e75391.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Scherzer R, Shen W, Bacchetti P, et\xc2\xa0al. Comparison of dual-energy X-ray absorptiometry and magnetic resonance imaging-measured adipose tissue depots in HIV-infected and control subjects. Am J Clin Nutr. 2008;88(4):1088-1096.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ 3rd, Khaltaev N. A reference standard for the description of osteoporosis. Bone. 2008;42(3):467-475.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Baumgartner RN, Koehler KM, Gallagher D, et\xc2\xa0al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147(8):755-763.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et\xc2\xa0al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age and ageing. 2010;39(4):412-423.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Centers for Disease Control and Prevention / National Center for Health Statistics. National Health and Nutrition Examination Survey Data. http://www.cdc.gov/nchs/nhanes.htm. Accessed May 12, 2014.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Chapple LS, Deane AM, Williams LT, et\xc2\xa0al. Longitudinal changes in anthropometrics and impact on self-reported physical function after traumatic brain injury. Crit Care Resusc. 2017;19(1):29-36.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Emmons RR, Garber CE, Cirnigliaro CM, Kirshblum SC, Spungen AM, Bauman WA. Assessment of measures for abdominal adiposity in persons with spinal cord injury. Ultrasound Med Biol. 2011;37(5):734-741.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Menon MK, Houchen L, Harrison S, Singh SJ, Morgan MD, Steiner MC. Ultrasound assessment of lower limb muscle mass in response to resistance training in COPD. Respir Res. 2012;13:119.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Seymour JM, Ward K, Sidhu PS, et\xc2\xa0al. Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD. Thorax. 2009;64(5):418-423.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Gong W, Ren H, Tong H, et\xc2\xa0al. A comparison of ultrasound and magnetic resonance imaging to assess visceral fat in the metabolic syndrome. Asia Pac J Clin Nutr. 2007;16(Suppl 1):339-345.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ribeiro-Filho FF, Faria AN, Kohlmann O, Jr., et\xc2\xa0al. Ultrasonography for the evaluation of visceral fat and cardiovascular risk. Hypertension. 2001;38(3 Pt 2):713-717.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Pontiroli AE, Pizzocri P, Giacomelli M, et\xc2\xa0al. Ultrasound measurement of visceral and subcutaneous fat in morbidly obese patients before and after laparoscopic adjustable gastric banding: comparison with computerized tomography and with anthropometric measurements. Obes Surg. 2002;12(5):648-651.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wagner DR. Ultrasound as a tool to assess body fat. J Obes. 2013;2013:280713.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Campbell IT, Watt T, Withers D, et\xc2\xa0al. Muscle thickness, measured with ultrasound, may be an indicator of lean tissue wasting in multiple organ failure in the presence of edema. Am J Clin Nutr. 1995;62(3):533-539.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Reid CL, Campbell IT, Little RA. Muscle wasting and energy balance in critical illness. Clin Nutr. 2004;23(2):273-280.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Sabatino A, Regolisti G, Bozzoli L, et\xc2\xa0al. Reliability of bedside ultrasound for measurement of quadriceps muscle thickness in critically ill patients with acute kidney injury. Clin Nutr. 2017;36(6):1710-1715.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Nijholt W, Scafoglieri A, Jager-Wittenaar H, Hobbelen JSM, van der Schans CP. The reliability and validity of ultrasound to quantify muscles in older adults: a systematic review. J Cachexia Sarcopenia Muscle. 2017;8(5):702-712.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Tillquist M, Kutsogiannis DJ, Wischmeyer PE, et\xc2\xa0al. Bedside ultrasound is a practical and reliable measurement tool for assessing quadriceps muscle layer thickness. JPEN J Parenter Enteral Nutr. 2014;38(7):886-890.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Paris MT, Mourtzakis M, Day A, et\xc2\xa0al. Validation of bedside ultrasound of muscle layer thickness of the quadriceps in the critically Ill patient (VALIDUM study). JPEN J Parenter Enteral Nutr. 2017;41(2):171-180.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Paris MT, Lafleur B, Dubin JA, Mourtzakis M. Development of a bedside viable ultrasound protocol to quantify appendicular lean tissue mass. J Cachexia Sarcopenia Muscle. 2017;8(5):713-726.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Alicandro G, Battezzati A, Bianchi ML, et\xc2\xa0al. Estimating body composition from skinfold thicknesses and bioelectrical impedance analysis in cystic fibrosis patients. J Cyst Fibros. 2015;14(6):784-791.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Bedogni G, Grugni G, Tringali G, Agosti F, Sartorio A. Assessment of fat-free mass from bioelectrical impedance analysis in obese women with Prader-Willi syndrome. Ann Hum Biol. 2015;42(6):538-542.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Beraldo RA, Vassimon HS, Navarro AM, Foss-Freitas MC. Development of predictive equations for total and segmental body fat in HIV-seropositive patients. Nutrition. 2015;31(1):127-131.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Dasarathy J, Periyalwar P, Allampati S, et\xc2\xa0al. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int. 2014;34(6):e118-127.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Trutschnigg B, Kilgour RD, Reinglas J, et\xc2\xa0al. Precision and reliability of strength (Jamar vs. Biodex handgrip) and body composition (dual-energy X-ray absorptiometry vs. bioimpedance analysis) measurements in advanced cancer patients. Appl Physiol Nutr Metab. 2008;33(6):1232-1239.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Reiss J, Iglseder B, Kreutzer M, et\xc2\xa0al. Case finding for sarcopenia in geriatric inpatients: performance of bioimpedance analysis in comparison to dual X-ray absorptiometry. BMC Geriatr. 2016;16:52.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Hung YC, Bauer JD, Horsely P, Ward LC, Bashford J, Isenring EA. Body composition following stem cell transplant: comparison of bioimpedance and air-displacement plethysmography. Nutrition. 2014;30(9):1000-1006.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Molfino A, Don BR, Kaysen GA. Comparison of bioimpedance and dual-energy x-ray absorptiometry for measurement of fat mass in hemodialysis patients. Nephron Clin Pract. 2012;122(3-4):127-133.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Pichler GP, Amouzadeh-Ghadikolai O, Leis A, Skrabal F. A critical analysis of whole body bioimpedance spectroscopy (BIS) for the estimation of body compartments in health and disease. Med Eng Phys. 2013;35(5):616-625.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Vine SM, Painter PL, Kuskowski MA, Earthman CP. Bioimpedance spectroscopy for the estimation of fat-free mass in end-stage renal disease. E Spen Eur E J Clin Nutr Metab. 2011;6(1):e1-e6.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Furstenberg A, Davenport A. Comparison of multifrequency bioelectrical impedance analysis and dual-energy X-ray absorptiometry assessments in outpatient hemodialysis patients. Am J Kidney Dis. 2011;57(1):123-129.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Furstenberg A, Davenport A. Assessment of body composition in peritoneal dialysis patients using bioelectrical impedance and dual-energy x-ray absorptiometry. Am J Nephrol. 2011;33(2):150-156.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Hosono O, Yoshikawa N, Shimizu N, et\xc2\xa0al. Quantitative analysis of skeletal muscle mass in patients with rheumatic diseases under glucocorticoid therapy-comparison among bioelectrical impedance analysis, computed tomography, and magnetic resonance imaging. Mod Rheumatol. 2015;25(2):257-263.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Perez-Matute P, Perez-Martinez L, Blanco JR, et\xc2\xa0al. Multiple frequency bioimpedance is an adequate tool to assess total and regional fat mass in HIV-positive patients but not to diagnose HIV-associated lipoatrophy: a pilot study. J Int AIDS Soc. 2013;16:18609.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Kaysen GA, Zhu F, Sarkar S, et\xc2\xa0al. Estimation of total-body and limb muscle mass in hemodialysis patients by using multifrequency bioimpedance spectroscopy. Am J Clin Nutr. 2005;82(5):988-995.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Hronek M, Kovarik M, Aimova P, et\xc2\xa0al. Skinfold anthropometry-the accurate method for fat free mass measurement in COPD. COPD. 2013;10(5):597-603.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Kyle UG, Genton L, Mentha G, Nicod L, Slosman DO, Pichard C. Reliable bioelectrical impedance analysis estimate of fat-free mass in liver, lung, and heart transplant patients. JPEN J Parenter Enteral Nutr. 2001;25(2):45-51.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>van Venrooij LM, Verberne HJ, de Vos R, Borgmeijer-Hoelen MM, van Leeuwen PA, de Mol BA. Preoperative and postoperative agreement in fat free mass (FFM) between bioelectrical impedance spectroscopy (BIS) and dual-energy X-ray absorptiometry (DXA) in patients undergoing cardiac surgery. Clin Nutr. 2010;29(6):789-794.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Zhu F, Levin NW. Estimation of body composition and normal fluid status using a calf bioimpedance technique. Blood Purif. 2015;39(1-3):25-31.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ida M, Hirata M, Odori S, et\xc2\xa0al. Early changes of abdominal adiposity detected with weekly dual bioelectrical impedance analysis during calorie restriction. Obesity (Silver Spring). 2013;21(9):E350-353.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Yamakage H, Ito R, Tochiya M, et\xc2\xa0al. The utility of dual bioelectrical impedance analysis in detecting intra-abdominal fat area in obese patients during weight reduction therapy in comparison with waist circumference and abdominal CT. Endocr J. 2014;61(8):807-819.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Kafri MW, Potter JF, Myint PK. Multi-frequency bioelectrical impedance analysis for assessing fat mass and fat-free mass in stroke or transient ischaemic attack patients. Eur J Clin Nutr. 2014;68(6):677-682.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Otto M, Farber J, Haneder S, Michaely H, Kienle P, Hasenberg T. Postoperative changes in body composition-comparison of bioelectrical impedance analysis and magnetic resonance imaging in bariatric patients. Obes Surg. 2015;25(2):302-309.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Aghdassi E, Arendt B, Salit IE, Allard JP. Estimation of body fat mass using dual-energy x-ray absorptiometry, bioelectric impedance analysis, and anthropometry in HIV-positive male subjects receiving highly active antiretroviral therapy. JPEN J Parenter Enteral Nutr. 2007;31(2):135-141.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lerario MC, Sachs A, Lazaretti-Castro M, Saraiva LG, Jardim JR. Body composition in patients with chronic obstructive pulmonary disease: which method to use in clinical practice? Br J Nutr. 2006;96(1):86-92.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Silva MI, Vale BS, Lemos CC, Torres MR, Bregman R. Body adiposity index assess body fat with high accuracy in nondialyzed chronic kidney disease patients. Obesity (Silver Spring). 2013;21(3):546-552.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Siqueira Vassimon H, Jordao AA, Albuquerque de Paula FJ, Artioli Machado A, Pontes Monteiro J. Comparison of bioelectrical impedance with skinfold thickness and X-ray absorptiometry to measure body composition in HIV-infected with lipodistrophy. Nutr Hosp. 2011;26(3):458-464.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ziai S, Coriati A, Chabot K, Mailhot M, Richter MV, Rabasa-Lhoret R. Agreement of bioelectric impedance analysis and dual-energy X-ray absorptiometry for body composition evaluation in adults with cystic fibrosis. J Cyst Fibros. 2014;13(5):585-588.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Donadio C, Halim AB, Caprio F, Grassi G, Khedr B, Mazzantini M. Single- and multi-frequency bioelectrical impedance analyses to analyse body composition in maintenance haemodialysis patients: comparison with dual-energy x-ray absorptiometry. Physiol Meas. 2008;29(6):S517-524.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Earthman CP. Body composition tools for assessment of adult malnutrition at the bedside: a tutorial on research considerations and clinical applications. JPEN J Parenter Enteral Nutr. 2015;39(7):787-822.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Gonzalez MC, Barbosa-Silva TG, Heymsfield SB. Bioelectrical impedance analysis in the assessment of sarcopenia. Curr Opin Clin Nutr Metab Care. 2018;21(5):366-374.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Gonzalez MC, Barbosa-Silva TG, Bielemann RM, Gallagher D, Heymsfield SB. Phase angle and its determinants in healthy subjects: influence of body composition. Am J Clin Nutr. 2016;103(3):712-716.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Bourgeois B, Fan B, Johannsen N, et\xc2\xa0al. Improved strength prediction combining clinically available measures of skeletal muscle mass and quality. J Cachexia Sarcopenia Muscle. 2018;10(1):84-94.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lukaski HC, Kyle UG, Kondrup J. Assessment of adult malnutrition and prognosis with bioelectrical impedance analysis: phase angle and impedance ratio. Curr Opin Clin Nutr Metab Care. 2017;20(5):330-339.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Cancello R, Zulian A, Gentilini D, et\xc2\xa0al. Molecular and morphologic characterization of superficial- and deep-subcutaneous adipose tissue subdivisions in human obesity. Obesity (Silver Spring). 2013;21(12):2562-2570.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Marinou K, Hodson L, Vasan SK, et\xc2\xa0al. Structural and functional properties of deep abdominal subcutaneous adipose tissue explain its association with insulin resistance and cardiovascular risk in men. Diabetes Care. 2014;37(3):821-829.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Carroll JF, Chiapa AL, Rodriquez M, et\xc2\xa0al. Visceral fat, waist circumference, and BMI: impact of race/ethnicity. Obesity (Silver Spring). 2008;16(3):600-607.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Kanaley JA, Giannopoulou I, Tillapaugh-Fay G, Nappi JS, Ploutz-Snyder LL. Racial differences in subcutaneous and visceral fat distribution in postmenopausal black and white women. Metabolism. 2003;52(2):186-191.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Katzmarzyk PT, Heymsfield SB, Bouchard C. Clinical utility of visceral adipose tissue for the identification of cardiometabolic risk in white and African American adults. Am J Clin Nutr. 2013;97(3):480-486.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Giusto M, Lattanzi B, Albanese C, et al. Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry. Eur J Gastroenterol Hepatol. 2015;27(3):328-334.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Gonzalez A, Bellido D, Buno MM, et al. Predictors of the metabolic syndrome and correlation with computed axial tomography. Nutrition (Burbank, Los Angeles County, Calif). 2007;23(1):36-45.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33(5):997-1006.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Olarescu NC, Jorgensen AP, Godang K, Jurik AG, Froslie KF, Bollerslev J. Dual-energy X-ray absorptiometry is a valid method to estimate visceral adipose tissue in adult patients with Prader-Willi syndrome during treatment with growth hormone. J Clin Endocrinol Metab. 2014;99(9):E1727-E1731.</Citation>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'